Carcinogen Concerns Trigger Review of Rifadin Syrup

Europe will be reviewing the tuberculosis medication following concerns raised by the Dutch medicines agency.
Medscape News Europe

Source link : https://www.medscape.com/viewarticle/carcinogen-concerns-trigger-review-rifadin-syrup-2026a1000luq?src=rss

Author :

Publish date : 2026-06-26 15:44:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30

Carcinogen Concerns Trigger Review of Rifadin Syrup

I have a 100 per cent chance of getting cancer due to a rare gene

New Data Lead to Decision to Revoke Autoimmune Disease Drug

Related Posts

988’s LGBTQ+ Hotline Is Relaunching. The Group That Helped Start It May Be Excluded.

European Regulators Move to Revoke Avacopan Authorization

What Journal Retracted a Hyped Cancer Study?

Scream, It’s Good for You; Release the Cancer Pigeons; Talk of Chemo Rationing

AI Smart Glasses Show Promise, Limitations as Aid for Patients With Low Vision

New Parkinson’s Drug Combines Immediate and Slow Release